000 | 01262 a2200337 4500 | ||
---|---|---|---|
005 | 20250513192648.0 | ||
264 | 0 | _c19991001 | |
008 | 199910s 0 0 eng d | ||
022 | _a0959-8049 | ||
024 | 7 |
_a10.1016/s0959-8049(98)00420-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBuske, C | |
245 | 0 | 0 |
_aMonoclonal antibody therapy for B cell non-Hodgkin's lymphomas: emerging concepts of a tumour-targeted strategy. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cApr 1999 |
||
300 |
_a549-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aChimera |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotoxins _xtherapeutic use |
650 | 0 | 4 |
_aLymphoma, B-Cell _xtherapy |
650 | 0 | 4 | _aRituximab |
700 | 1 | _aFeuring-Buske, M | |
700 | 1 | _aUnterhalt, M | |
700 | 1 | _aHiddemann, W | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 35 _gno. 4 _gp. 549-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(98)00420-1 _zAvailable from publisher's website |
999 |
_c10449934 _d10449934 |